News and Announcements
CEO Dr James Garner speaks about GDC-0084 data with Proactive Investors
- Published November 25, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Our CEO, Dr James Garner discussed the significance of the interim efficacy data from Kazia’s phase II trial of GDC-0084 in glioblastoma in an interview with Proactive Investors.
In the interview, Dr Garner talks about:
- How the median progression-free survival rate of 8.3 months strongly suggests that GDC-0084 is delaying the progression of glioblastoma in the patients treated
- How the data signals that GDC-0084 may be extending life expectancy for the patients treated
- How the data compares to the existing treatment option for glioblastoma, temozolomide
- The next steps for the phase II study and Kazia more generally
Watch the video interview here
About KaziaTherapeutics Limited
Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA) is an innovative oncology-focused biotechnology company, based in Sydney, Australia. Our pipeline includes two clinical-stage drug development candidates, and we are working to develop therapies across a range of oncology indications.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
